Skip to main content
. 2018 Nov 16;65(13):1–23. doi: 10.15585/mmwr.ss6513a1

TABLE 7. Comparison of autism spectrum disorder prevalence among sites with comparable surveillance areas in 2010 and 2012, by record source type, sex, and race/ethnicity, Autism and Developmental Disabilities Monitoring Network, eight sites, United States.

Characteristic 2010
2012
2012-to-2010 prevalence ratio (95% CI)
Prevalence (95% CI) Prevalence (95% CI)
Record source
E+H areas*
17.5 (16.9–18.2)
17.6 (17.0–18.3)
1.00 (0.95–1.05)
HO areas
10.8 (10.1–11.4)
11.0 (10.3–11.7)
1.02 (0.94–1.11)
E+H-to-HO prevalence ratio
1.6 (1.5–1.7)
1.6 (1.5–1.7)
§
Site
Arizona
15.7 (14.4–17.1)
15.1 (13.9–16.5)
0.97 (0.85–1.09)
Colorado
9.9 (9.0–10.9)
10.8 (9.8–11.8)
1.09 (0.95–1.25)
Georgia
15.5 (14.5–16.7)
15.5 (14.5–16.6)
1.00 (0.90–1.10)
Missouri
14.2 (12.8–15.7)
11.6 (10.4–13.0)
0.82 (0.70–0.96)
New Jersey
21.9 (20.4–23.6)
24.6 (23.0–26.4)
1.11 (1.01–1.23)
North Carolina
17.3 (16.1–18.7)
16.8 (15.5–18.1)
0.97 (0.87–1.08)
Utah
18.6 (17.0–20.4)
17.3 (15.7–19.0)
0.93 (0.81–1.06)
Wisconsin
9.3 (8.3–10.3)
10.8 (9.8–11.9)
1.17 (1.01–1.35)
Sex
Male
24.4 (23.6–25.2)
24.6 (23.8–25.4)
1.01 (0.96–1.05)
Female
5.4 (5.0–5.8)
5.5 (5.1–5.9)
1.02 (0.92–1.13)
Male-to-female prevalence ratio
4.5 (4.2–4.9)
4.5 (4.1–4.8)

Race/Ethnicity
White, non-Hispanic
16.2 (15.5–16.8)
16.5 (15.8–17.2)
1.02 (0.96–1.08)
Black, non-Hispanic
12.9 (12.0–13.9)
13.9 (12.9–14.9)
1.08 (0.97–1.19)
Hispanic
11.2 (10.4–12.1)
10.5 (9.7–11.3)
0.93 (0.84–1.04)
White-to-black prevalence ratio
1.3 (1.2–1.4)
1.2 (1.1–1.3)

White-to-Hispanic prevalence ratio
1.4 (1.3–1.6)
1.6 (1.4–1.7)

Black-to-Hispanic prevalence ratio
1.2 (1.0–1.3)
1.3 (1.2–1.5)

Total 15.1 (14.6–15.5) 15.2 (14.815.7) 1.01 (0.971.05)

Abbreviations: CI = confidence interval; E+H = education and health records review; HO = health records only review.

*Sites reviewing education and health records: Arizona, Georgia, New Jersey, North Carolina, and Utah.

Sites reviewing health records only: Colorado, Missouri, and Wisconsin.

§Ratios of prevalence ratios were not calculated.